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Popularization of tension-free vaginal mesh surgery for the treatment of pelvic
organ prolapse in Japan: A retrospective review of the ﬁrst 50 procedures
performed by a gynecologistDear Editor,
As Japan becomes a super-aging society, with 1 in 5 people
aged 65 years or older, the range of activities for the elderly is
also becoming wider. Pelvic organ prolapse (POP) is a serious
disease that carries an increased risk for surgery by the age of
80 years in up to 11% of the female population and it signiﬁcantly
affects women’s quality of life (QOL).1 Urinary incontinence (UI) is
another urogynecologic disease that is closely associated with POP
and increases in incidence with advancing age.2,3 Permanent cure
of POP can be achieved surgically, and Japanese gynecologists have
traditionally performed curative surgical procedures such as
vaginal hysterectomy (VH), anterior or posterior colpoplasty, and
circumferential suture of the levator ani muscle for POP, and espe-
cially for uterine prolapse. With a trend toward seeking less inva-
sive surgical procedures, in the last decade a French group of
gynecologists described tension-free vaginal mesh (TVM) surgery
for the repair of POP using a mesh without hysterectomy.4,5 In
Japan, this surgical procedure was ﬁrst adopted by urologists,6 fol-
lowed by gynecologists and is now becoming the ﬁrst-line surgical
option for POP-substituting VH in Japan. However, while surgical
kits for TVM are commercially available in Western countries,
such products have not received approval from the government
in Japan, and surgeons must therefore cut a polypropylene mesh
into the same shape as that provided in a commercially available
kit which enables the mesh arms to penetrate through the obtu-
rator foramen and the sacrospinous ligament with a custom-
made needle. Unlike VH, in which surgical manipulation is per-
formed under macroscopic observation, TVM surgery consists
mainly of blind techniques and is thus associated with not only
procedure-speciﬁc complications, such as bladder and rectal
injury, but also postoperative complications, such as dyspareunia
and urinary incontinence. Indeed, a randomized controlled trial
showed higher rates of surgical complications and postoperative
adverse events in mesh surgery compared to that in conventional
surgery.7
At the Department of Obstetrics and Gynecology, Shimane
University School of Medicine, we have employed TVM surgery
for the treatment of POP since September 2009. Japanese govern-
ment approved TVM surgery as a remedy for POP and the cost of treat-
ment is covered by the public health insurance for the whole nation in
our country. We report here the clinical outcome of the ﬁrst 50
patients with POP who underwent TVM surgery performed solely
by the ﬁrst author, a gynecologist who had no prior experience of1743-9191/$ – see front matter  2012 Surgical Associates Ltd. Published by Elsevier Lt
http://dx.doi.org/10.1016/j.ijsu.2012.06.007TVM surgery, with the intention of showing that the TVM tech-
nique can be performed relatively easily and safely, even by
a ﬁrst-time surgeon.
Of these 50 patients, 18 with cystocele underwent anterior TVM
(A-TVM) in which a mesh was inserted into the anterior vaginal
wall alone, 21 with cystocele underwent anterior and posterior
TVM (AP-TVM) in which meshes were inserted into both the ante-
rior and posterior vaginal walls, 9 with cystocele underwent total
TVM (T-TVM) in which a mesh consisting of two parts for the ante-
rior and posterior walls connected to each other was inserted into
a vaginal vault prolapse following hysterectomy, and 2 patients
with rectocele underwent posterior TVM (P-TVM) in which
a mesh was inserted into the posterior vaginal wall alone. POP-Q
stage, operation time, and intraoperative bleeding volume for
patients who underwent the TVM procedure are summarized in
Table 1. Mean operation time was 72.23  17.17 min for A-TVM,
106.70  16.26 min for AP-TVM, 97.11  22.77 min for T-TVM,
and 66.5  23.334 min for P-TVM. Intraoperative bleeding volume
was not measurable and was therefore recorded as <30 ml, 30–
50 ml, or 50–100 ml, or >100 ml. Four patients in total had
>100 ml of bleeding during surgery, with 1 patient having
1800 ml of bleeding.
Antibiotic prophylaxis was administered until postoperative day
(POD) 5. We removed the balloon catheter on the morning of POD2
and discontinued measurement of residual urine if the volume was
<100 ml. Ten (21.6%) patients had >100 ml of residual urine at the
initial measurement, but measurement was discontinued in all
patients if volume decreased to <100 ml by discharge on POD3
(Table 2).
Possible intraoperative complications of TVM surgery include
bladder and rectal injury caused by needle insertion, vaginal wall
hematoma, and massive transfusion. Among the 50 cases, the
only intraoperative complication encountered was 1800 ml of
bleeding requiring transfusion in one patient. There were no cases
of bladder injury, rectal injury, vaginal hematoma, or hydronephro-
sis. Postoperative complications were reviewed for all 50 patients
who were followed for at least 3 months. Neither postoperative
recurrence of uterine prolapse nor mesh exposure has occurred
thus far. One (2.0%) patient complained of tightening of the lower
abdomen at 1-month follow-up, but the symptom had resolved
by the 3-month follow-up visit. Twelve (24.0%) patients experi-
enced postoperative new onset of stress urinary incontinence
(SUI) while 6 (12.0%) reported worsening of existing urinary
incontinence.d. All rights reserved.
Table 1
Surgical characteristics of the tension-free vaginal mesh (TVM) procedure.
n ¼ 50 POP-Q Operation
time (min)
Blood loss (ml)
II III IV <30 30–50 50–100 >100
Anterior TVM 18 8 10 0 72.23  17.17 14 2 1 1 (330)
Anterior and
posterior
TVM
21 4 15 2 106.7  16.26 11 5 2 3 (100,
130,
1800)
Total TVM 9 3 6 0 97.11  22.77 5 1 3 0
Posterior TVM 2 2 0 0 66.5  23.33 2 0 0 0
Table 3
Status of postoperative stress urinary incontinence (SUI).
Pre-operation SUI (absent)
23 (46.0)
SUI (present)
27 (54.0)
Post-operation
SUI (absent) 11 (47.8) 6 (22.2)
SUI (present) 12 (52.2) 21 (77.8)
no change 15 (71.4)
worsened 6 (28.6)
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between preoperative urinary symptoms and postoperative
complications. Of the 23 (46.0%) patients without preoperative
incontinence, 12 (52.2%) experienced postoperative onset of SUI.
On the other hand, 6 of 27 (22.2%) patients with preoperative SUI
reported resolution after TVM surgery. The remaining 21 (77.8%)
continued to experience urinary incontinence even after surgery,
of whom 15 (71.4%) reported unchanged symptoms and 6 (28.6%)
reported worsening of urinary incontinence symptoms (Table 3).
The data presented here are from the ﬁrst 50 cases performed
solely by the ﬁrst author and provide helpful information for
surgeons who are interested in employing this surgical procedure.
A randomized controlled trial to compare the TVM procedure with
conventional VH surgery demonstrated the signiﬁcant superiority
of TVM in terms of cure rate.8 TVM is also associated with relatively
few complications and can thus be performed safely.6 This is likely
why TVM is becoming popular among Japanese gynecologists and
is considered by many to be a suitable ﬁrst-line option for POP
patients. At the same time, however, there have been reports of
TVM-speciﬁc intraoperative and postoperative complications,
such as unexpected bleeding, pelvic hematoma formation, injury
to the urinary bladder and rectum, mesh exposure, and dyspareu-
nia, which led to an FDA warning issued in 2008 (Vaginal Mesh
FDA Warning: Serious complications associated with transvaginal
placement of surgical mesh in repair of pelvic organ prolapse and
stress urinary incontinence, 2008). As part of the informed consent
process, patients need to be fully informed of the risk for postoper-
ative onset of SUI. Among our 50 patients who underwent surgery
for POP and were followed for at least 3 months, 27 (54.0%) had SUI
prior to surgery. Among them, 6 (22.2%) reported improvement and
6 (28.6%) reported worsening of incontinence after surgery. More-
over, 12 of 23 (52.2%) patients without preoperative incontinence
reported postoperative onset. These ﬁndings suggest, albeit based
on a small number of cases in this preliminary study, that TVM
surgery does not improve but may rather induce urinary inconti-
nence. In all cases of postoperative new onset or worsening of
urinary incontinence, however, symptoms were improved or
resolved without the need for surgical intervention by urologists,
such as by using tension-free vaginal tape and trans-obturator
tape. Further studies are needed to identify subgroups of patients
likely to undergo improvement or new onset or worsening of
urinary incontinence after surgery.Table 2
Residual urine volume after removal of uterine catheter.
Residual urine volume (ml) No. of patients
<50 22
<100 16
<150 5
<200 2
<300 3Based on the experiences of the ﬁrst author who undertook all
50 TVM procedures reported on herein, TVM can be performed
relatively easily, even by a surgeon inexperienced in the proce-
dure. Moreover, as we reported previously in a review of the ﬁrst
20 procedures undertaken by the ﬁrst author, the TVM technique
is not experience-dependent in regard to operation time.9 We
therefore expect that this technique will become increasingly
accepted by obstetricians and gynecologists as a standard surgical
procedure for POP, replacing the conventional procedure. In
another Japanese study, quality of life (QOL) parameters such as
short Form-36 and prolapse-QOL scores were signiﬁcantly
improved among Japanese women who underwent TVM proce-
dure, although a number of postoperative complications were re-
ported.6 Because we have reviewed our ﬁrst 50 cases of TVM
surgery which were followed for a minimum of 3 months only
at this stage, we plan to gather and report on longer follow-up
data, including QOL, over time.
Since TVM is associatedwith the risk of inducing SUI, a condition
not usually treated by obstetricians and gynecologists, such profes-
sionals should improve their understanding of the pathogenesis of
various types of urinary incontinence and of speciﬁc tests, such as
urodynamic study, and cooperate with urologists in treating POP.
Although we expect that TVM surgery will continue to be adopted
by an increasing number of obstetricians and gynecologists,
including those inexperienced in the procedure, it is needless to
add that surgeons who attempt to apply this procedure clinically
should have a full understanding of pelvic anatomy and POP.
Cadaver model training and observing or assisting experienced
surgeons would be valuable for the inexperienced and they should
receive guidance from an experienced surgeon prior to practical
training.
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